Does DABIGATRAN Cause Incorrect product administration duration? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Incorrect product administration duration have been filed in association with DABIGATRAN. This represents 0.3% of all adverse event reports for DABIGATRAN.
6
Reports of Incorrect product administration duration with DABIGATRAN
0.3%
of all DABIGATRAN reports
0
Deaths
6
Hospitalizations
How Dangerous Is Incorrect product administration duration From DABIGATRAN?
Of the 6 reports, 6 (100.0%) required hospitalization.
Is Incorrect product administration duration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN Cause?
Gastrointestinal haemorrhage (210)
Hypotension (167)
Atrial fibrillation (150)
Drug interaction (143)
Haemorrhage (141)
Anaemia (131)
Dizziness (123)
Acute kidney injury (120)
Drug ineffective (118)
Fall (117)
What Other Drugs Cause Incorrect product administration duration?
ETONOGESTREL (3,974)
POLYETHYLENE GLYCOL 3350 (2,129)
NIRMATRELVIR\RITONAVIR (744)
DOCOSANOL (634)
LANSOPRAZOLE (564)
LOPERAMIDE (543)
NAPROXEN (499)
INSULIN LISPRO (479)
DICLOFENAC (362)
OMEPRAZOLE (302)
Which DABIGATRAN Alternatives Have Lower Incorrect product administration duration Risk?
DABIGATRAN vs DABIGATRAN ETEXILATE
DABIGATRAN vs DABRAFENIB
DABIGATRAN vs DABRAFENIB\TRAMETINIB
DABIGATRAN vs DACARBAZINE
DABIGATRAN vs DACLATASVIR